Unknown PHASE2 INTERVENTIONAL 2-arm NCT03281226

RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/TB Co-infection (RIPENACTB)

An Open Label Randomized Phase 2 Clinical Trial to Assess Safety and Tolerability of RIPE vs RIPE Plus N-acetylcysteine in Patients With HIV/Aids and Pulmonary Tuberculosis

Sponsor: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

Conditions HIV/AIDS Tuberculosis, Pulmonary

Interventions RIPE (2m) and RI (4m) RIPE+NAC (2m) and RI (4m)

Updated 7 times since 2017 Last updated: Feb 12, 2019 Started: Dec 7, 2016 Primary completion: Jun 30, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates HIV/AIDS and Tuberculosis, Pulmonary and is currently ongoing. Fundação de Medicina Tropical Dr. Heitor Vieira Dourado leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE2
Mar 2019 — Jan 2021 [monthly]

Recruiting PHASE2

▶ Show 2 earlier versions

Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE2
Oct 2017 — Jun 2018 [monthly]

Recruiting PHASE2

First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

Data source: Fundação de Medicina Tropical Dr. Heitor Vieira Dourado

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manaus, Brazil